AVGO vs EBS · P/E 87, rev $41.50B vs rev $1.04B
Broadcom Inc (AVGO) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Broadcom Inc (AVGO) is a semiconductors company listed on US. It is led by Hock Tan.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AVGO revenue for 2026-05-03 was $41.50B. Net income was $16.66B. AVGO currently screens at market cap $2.12T and trailing P/E 86.9.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
AVGO currently screens at market cap $2.12T and trailing P/E 86.9. EBS currently screens at market cap $416.4M.
Not investment advice. Open the AVGO and EBS stock pages for the full models.
Not investment advice.